TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
CGEN

Compugen

Healthcare · Biotechnology

2.10$ -1.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Compugen (CGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 138 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGEN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
78 71 64 56 47 39 39 51 51 53 51 48 57 54 131 146 143 138 130 123 121 132 121 110 99 94 84 77 68 121 114 110 124 115 115 107 98 157 146 138
69 63 56 48 39 31 32 44 44 47 40 38 48 45 122 137 134 129 121 114 112 123 112 102 91 86 76 69 60 115 106 102 115 106 107 98 89 148 137 129
68 62 54 17 38 30 21 10 35 46 38 5.6 48 44 121 12 133 7.1 119 7.8 102 7.8 107 8.0 88 11 74 62 48 14 69 12 7.2 18 15 6.5 7.5 91 12 10
68 62 54 45 38 30 21 42 35 46 38 36 48 44 121 135 133 124 119 110 102 117 107 97 88 83 74 67 58 51 101 92 113 103 104 94 86 146 135 125
1.2 0.1 1.4 1.4 0.9 0.7 11 1.3 9.6 0.2 1.5 0.8 0.7 0.3 1.1 1.1 1.3 2.0 1.7 2.7 10 0.2 5.3 4.7 2.8 0.3 2.1 2.9 2.8 61 4.3 9.8 2.1 0.3 3.1 3.8 2.8 0.3 2.3 4.1
– -2.1 – – – -1.7 – – – -1.3 – – – -1.4 – – – -3.1 -1.7 – -4.0 -6.0 -5.3 – -2.8 -73 -2.1 -2.9 -2.8 – -4.3 – – – – – – – – –
6.1 6.0 5.6 5.3 4.9 4.6 4.3 4.0 3.7 3.4 7.8 7.3 5.9 5.6 5.3 5.0 4.7 4.5 4.2 4.1 4.0 3.9 3.8 3.6 3.5 3.4 – 3.0 – – – – – – – – – – – –
7.6 7.6 8.4 8.4 9.1 9.4 8.7 10 13 16 18 16 15 15 17 16 16 19 19 19 22 25 23 20 20 16 15 15 14 56 54 52 63 60 58 56 54 54 51 50
4.7 4.7 5.3 5.1 5.9 6.2 5.5 7.5 9.7 10.0 7.8 7.0 6.7 6.8 8.7 8.1 7.9 11 11 12 15 17 16 14 15 12 11 11 10 26 25 25 28 20 21 21 20 23 22 23
– – – – – 0.3 – – – – 1.1 1.2 0.6 0.6 0.5 0.5 0.5 0.6 0.7 0.7 0.8 0.8 0.8 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.6
4.6 1.3 5.3 2.1 5.9 3.4 5.5 1.8 9.7 2.9 5.6 1.2 5.2 1.1 7.4 1.1 6.8 1.4 10 1.8 14 4.6 11 2.2 13 1.8 10 1.7 9.8 3.5 13 2.4 11 1.8 11 1.8 9.1 2.4 2.5 2.2
– – – – – – – – – 3.0 3.8 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
70 64 56 47 38 29 30 41 38 37 33 32 42 38 114 129 127 120 111 103 99 107 98 90 80 78 69 62 53 66 60 58 60 55 57 50 44 103 95 89
-271 -271 – -289 – -308 – -318 – -331 – -345 -345 -358 – -372 – -388 – -407 – -422 – -441 – -456 – -474 – -475 – -484 – -489 – -503 – -453 – -468
51 51 51 51 51 51 52 53 57 60 60 61 65 68 70 81 83 84 84 84 84 85 86 87 87 87 87 87 88 88 90 90 90 90 92 94 94 95 95 95

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?